Article Versions Notes

Yoshita M, Funaki M, Shimakami T, Kakuya M, Murai K, Sugimoto S, Kawase S, Matsumori K, Kawane T, Nishikawa T, et al. High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine. Viruses. 2024; 16(8):1346. https://doi.org/10.3390/v16081346

Yoshita, Mika, Masaya Funaki, Tetsuro Shimakami, Masaki Kakuya, Kazuhisa Murai, Saiho Sugimoto, Shotaro Kawase, Koji Matsumori, Taro Kawane, Tomoki Nishikawa, and et al. 2024. "High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine" Viruses 16, no. 8: 1346. https://doi.org/10.3390/v16081346

Yoshita, M., Funaki, M., Shimakami, T., Kakuya, M., Murai, K., Sugimoto, S., Kawase, S., Matsumori, K., Kawane, T., Nishikawa, T., Nakamura, A., Suzuki, R., Ishida, A., Kawasaki, N., Sato, Y., Li, Y.-Y., Sumiyadorj, A., Nio, K., Takatori, H., ... Yamashita, T. (2024). High-Throughput Screening of Antiviral Compounds Using a Recombinant Hepatitis B Virus and Identification of a Possible Infection Inhibitor, Skimmianine. Viruses, 16(8), 1346. https://doi.org/10.3390/v16081346